• Nov 22 2024 This Week in Cardiology

  • Nov 22 2024
  • Length: 32 mins
  • Podcast

Nov 22 2024 This Week in Cardiology

  • Summary

  • An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week’s podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. OPTION Trial

    For AF, LAA Rivals Anticoagulants After Ablation

    https://www.medscape.com/viewarticle/af-laa-rivals-anticoagulants-after-ablation-2024a1000l7n

    4 Reasons to Question Percutaneous Left Atrial Appendage Closure After AF Ablation

    https://www.medscape.com/viewarticle/4-reasons-question-percutaneous-left-atrial-appendage-2024a1000l0u

    • OPTION in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2408308

    II. SUMMIT Trial

    Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity

    https://www.medscape.com/viewarticle/tirzepatide-reduces-heart-failure-events-hfpef-obesity-2024a1000kx5

    • SUMMIT in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2410027

    III. VANISH Trial

    New Trial Result Pushes Past Antiarrhythmic Therapy After MI

    https://www.medscape.com/viewarticle/new-trial-result-pushes-past-antiarrhythmic-therapy-after-mi-2024a1000l08

    • VANISH 2 https://www.nejm.org/doi/full/10.1056/NEJMoa2409501
    • VANISH 1 https://www.nejm.org/doi/full/10.1056/NEJMoa1513614

    IV. Cardioprotection

    Common Heart Failure Drugs Ease Heart Damage During Chemo https://www.medscape.com/viewarticle/common-heart-failure-drugs-ease-heart-damage-during-chemo-2024a1000l14

    • Strain Imaging Review Article https://www.jacc.org/doi/10.1016/j.jcmg.2024.07.011

    V. CLEAR trial

    Spironolactone Shows Mixed Results in Acute MI

    https://www.medscape.com/viewarticle/spironolactone-shows-mixed-results-acute-mi-2024a1000l41

    Routine Colchicine or MRA Post-MI: No CLEAR Benefit

    https://www.medscape.com/viewarticle/routine-colchicine-or-mra-post-mi-no-clear-benefit-2024a1000la2

    • CLEAR-Spironolactone https://www.nejm.org/doi/full/10.1056/NEJMoa2405923
    • CLEAR-Colchicine https://www.nejm.org/doi/full/10.1056/NEJMoa2405922

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less

What listeners say about Nov 22 2024 This Week in Cardiology

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.